Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

India Remdesivir Saga: Exports Barred, Ramp Up Plans And Panic

Supply Situation Seen Easing

Apr 13 2021

• By Anju Ghangurde

Banja Luka, Bosnia and Herzegovina, 18.3.2020. Concept of medical bottle with new possible cure for Coronavirus COVID 19. Remdesivir therapy for Korona virus medication potential drug — Remedesivir Supply Gap In India As COVID-19 Cases Spike • Source: Shutterstock

Related Content

Pandemic Perspectives: US FDA ACTT’s On Its Faith In Randomized Trials With Veklury Approval Despite WHO Study

Mar 16 2021

Gilead Licenses Remdesivir To Five Firms

May 13 2020

Pandemic Perspectives: Remdesivir, Favipiravir’s Eventful Journeys In India A Year On

Mar 17 2021

WHO No-Go Not A Swan Song For Remdesivir In India?

Nov 30 2020

India Remdesivir Black Market: Supply Gap May Normalize Soon, But No End To Greed

Jul 20 2020

Gilead Licensing Deal Expands Remdesivir Access, Capacity

May 13 2020

Coronavirus Update: No Mortality Gains From Remdesivir In WHO Trial, Gilead Questions Results

Oct 16 2020

Related Companies

Gilead Sciences, Inc.

Hetero Drugs Ltd.

Cipla Limited

Dr. Reddy's Laboratories Ltd.

Syngene International Ltd.

Zydus Lifesciences Limited

Additional Topics

India Asia Pacific Coronavirus COVID-19 BioPharmaceutical

More from Archive

More from Generics Bulletin

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window